Fact CheckerSign in

NCT06885684Not yet recruiting

Cognitive Control and Metacognition Training

Developing Cognitive Control and Metacognition to Reduce the Functional Impact of Restricted and Repetitive Behaviors in Autism

Source: ClinicalTrials.gov · Last updated 27 Apr 2026

Brief summary (registry, in English)

95 autistic children (ages 8-11yrs) will be randomly assigned to a novel computer-based Cognitive Control Training combined with Metacognition Coaching or to a comparison group that receives the intervention after a delay. Before and after intervention, electroencephalography (EEG) will be used to examine engagement of the target neural responses.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
95 (estimated)
First submitted
11 Mar 2025
Start date
30 Jun 2026
Primary completion date
28 Feb 2028
Lead sponsor
Boston Children's Hospital
Diseases
Autism
NCT number
NCT06885684

What you commit to

  • Study type: Interventional
  • Planned participants: 95
  • From 30 Jun 2026 to the primary completion date, 28 Feb 2028
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Children must not have a known genetic condition related to autism (e.g., Fragile X)
  • Children must not have medical conditions/injuries, exposure to substances, or significant deprivation with implications for the central nervous system or that require regular psychoactive medications that alter EEG responses (anticonvulsants, barbiturates) \*
  • Children must not have seizures or a seizure disorder (other than history of febrile seizures)
  • Children must not have significant sensory or motor impairment or major physical abnormalities that would limit the ability to participate in table top or EEG testing, or make responding during computer activities difficult

Other

  • Children must not have a failed screening for colorblindness

Who the study is looking for

  • Children should be 8 to 11 years of age
  • Children should have an existing diagnosis of an autism spectrum disorder, which will be confirmed using research measures and criteria
  • Children must have general cognitive ability in the average range or above (above 80 using the Wechsler Abbreviated Scale of Intelligence-2 Full Scale IQ)
  • Caregivers and children must be fluent in English or Spanish

Age in the registry: 8 years to 11 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.